Freshly Printed - allow 7 days lead
Couldn't load pickup availability
Enzyme Technologies
Pluripotent Players in Discovering Therapeutic Agent
Hsiu-Chiung Yang (Author), Wu-Kuang Yeh (Author), J. R. McCarthy (Author)
9780470286265, Wiley
Hardback, published 18 February 2014
356 pages
24.1 x 16.4 x 2.4 cm, 0.667 kg
“The book serves as a valuable desk reference volume and describes well the key concepts of the standard and emerging enzyme technologies that together constitute some of the fundamental principles and knowledge on which drug discovery research is based.” (ChemMedChem, 1 August 2015)
Sets the stage for advances in drug discovery using the latest enzyme technology Reviewing new and emerging applications of enzyme technology in drug discovery, this book highlights some of the most promising areas of pharmaceutical and biotechnology research. It covers enzyme assay technology, utilization of enzymology for prodrug design, and the application of enzymes as therapeutic agents. Expert reviews highlight how our latest understanding of enzymology is used to develop new practical applications in drug discovery and design. Filled with case studies, Enzyme Technologies: Pluripotent Players in Discovering Therapeutic Agents enables readers to better understand the diverse functions of enzymes and master specific applications in drug discovery research. In addition to small molecule drug discovery, the book explores new developments in enzymes as therapeutic agents for genetic disorders. Chapters are contributed by leading experts from around the world. Their contributions are based on a thorough review of the current literature as well as their own research. Reviewing our latest understanding of the nature of enzymes and their role in drug discovery, this book is recommended for researchers in pharmaceuticals and biotechnology as well as for researchers in enzymology, biochemistry, molecular biology, and medicinal chemistry.
Contributors vii Preface ix Part A _Enzymes – essential workhorses in pharmaceutical research 1 1 Assay Technologies for Proteases 3 2 Discovery and Development of Isozyme-Selective Inhibitors Involved in Lipid Metabolism 55 3 Covalent Enzyme Inhibition in Drug Discovery and Development 81 4 Preclinomics: Enzyme Assays and Rodent Models for Metabolic diseases 131 Part B _Enzymes – indispensable tools for improving druggability 163 5 Enzymes and Targeted Activation of Prodrugs 165 6 Evolution of an Orally Active Prodrug of Gemcitabine 237 7 Enzymatically Activated Phosphate and Phosphonate Prodrugs 253 Part C E nzymes – powerful weapons for correcting Nature’s errors 301 8 Treatment Options for Mucopolysaccharidosis Type II (Hunter’s Syndrome) 303 9 Enzyme Replacement Therapy for Fabry Disease 321 10 Methods and Principles of Pancreatic Function Tests 335 Index 341
Anuradha Roy, Gerald H. Lushington, James McGee, and Rathnam Chaguturu
Taichi Ohshiro and Hiroshi Tomoda
Shujaath Mehdi
Wu-Kuang Yeh and Richard G. Peterson
Yanhui Yang, Yu Chen, Herve Aloysius, Daigo Inoyama, and Longqin Hu
James R. McCarthy
Ivan S. Krylov and Charles E. McKenna
Michael Beck
Ley Nadine Lacbawan, Wei Zheng, and Ozlem Goker-Alpan
Henrike von Schassen, Jutta Keller, and Peter Layer
Subject Areas: Biology, life sciences [PS]
